The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) - Contacts and Locations


United States, Arizona
	GSK Investigational Site
	Phoenix, Arizona, United States, 85013 - 4496

United States, Arkansas
	GSK Investigational Site
	Little Rock, Arkansas, United States, 72205

United States, California
	GSK Investigational Site
	Los Angeles, California, United States, 90057
	GSK Investigational Site
	Fountain Valley, California, United States, 92708
	GSK Investigational Site
	Bakersfield, California, United States, 93309

United States, Florida
	GSK Investigational Site
	Gainesville, Florida, United States, 32610

United States, Indiana
	GSK Investigational Site
	Indianapolis, Indiana, United States, 46260

United States, Kentucky
	GSK Investigational Site
	Lexington, Kentucky, United States, 40536-0098

United States, Louisiana
	GSK Investigational Site
	Shreveport, Louisiana, United States, 71103
	GSK Investigational Site
	New Orleans, Louisiana, United States, 70112
	GSK Investigational Site
	New Orleans, Louisiana, United States, 70121

United States, Maine
	GSK Investigational Site
	Scarborough, Maine, United States, 04074

United States, Massachusetts
	GSK Investigational Site
	Springfield, Massachusetts, United States, 01107

United States, Minnesota
	GSK Investigational Site
	Minneapolis, Minnesota, United States, 55455
	GSK Investigational Site
	Duluth, Minnesota, United States, 55805
	GSK Investigational Site
	Robbinsdale, Minnesota, United States, 55422

United States, Missouri
	GSK Investigational Site
	St. Louis, Missouri, United States, 63141

United States, Montana
	GSK Investigational Site
	St. Louis, Montana, United States, 63110

United States, New Mexico
	GSK Investigational Site
	Albuquerque, New Mexico, United States, 87109

United States, North Carolina
	GSK Investigational Site
	Raleigh, North Carolina, United States, 27609

United States, Ohio
	GSK Investigational Site
	Toledo, Ohio, United States, 43614-5809
	GSK Investigational Site
	Cincinnati, Ohio, United States, 45236
	GSK Investigational Site
	Akron, Ohio, United States, 44304
	GSK Investigational Site
	Cleveland, Ohio, United States, 44106

United States, Texas
	GSK Investigational Site
	Fort Worth, Texas, United States, 76104
	GSK Investigational Site
	San Antonio, Texas, United States, 78229

United States, Wisconsin
	GSK Investigational Site
	Madison, Wisconsin, United States, 53792
	GSK Investigational Site
	Wausau, Wisconsin, United States, 54401
	GSK Investigational Site
	Green Bay, Wisconsin, United States, 54301
	GSK Investigational Site
	Milwaukee, Wisconsin, United States, 53215
	GSK Investigational Site
	La Crosse, Wisconsin, United States, 54601

GlaxoSmithKline


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline